Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib [RNA-seq]
GEO Series GSE154041. Homo sapiens. 71 samples. Type: Expression profiling by high throughput sequencing.
Differential T-cell and monocyte responses in hepatocellular carcinoma treated with regorafenib plus nivolumab: an integrated clinical and biomarker analysis of the phase 2 RENOBATE trial
GEO Series GSE243572. Homo sapiens. 53 samples. Type: Expression profiling by high throughput sequencing; Other.
RNA Sequencing of a Phase Ib/II Study of Regorafenib and Paclitaxel in Patients with Beyond First-line Advanced Esophagogastric Carcinoma (REPEAT)
GEO Series GSE198136. Homo sapiens. 34 samples. Type: Expression profiling by high throughput sequencing.
Transcriptomic changes induced by regorafenib in sorafenib-resistant hepatocellular carcinoma cells: role of TGF-beta signaling and lncRNAs
GEO Series GSE242333. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing; Non-coding RNA profiling by high throughput sequencing.
A methylome-based score to predict response to regorafenib in recurrent glioblastoma
GEO Series GSE283494. Homo sapiens. 33 samples. Type: Methylation profiling by genome tiling array.
Synergistic combination therapies involving regorafenib in experimental glioma based on genome-wide CRISPR-Cas9 functional screens
GEO Series GSE272737. Homo sapiens. 24 samples. Type: Expression profiling by high throughput sequencing.
AUTOPHAGY INHIBITION IMPROVES SENSITIVITY TO THE MULTI-KINASE INHIBITOR REGORAFENIB IN PRECLINICAL MOUSE COLON TUMOROIDS
GEO Series GSE297312. Mus musculus. 43 samples. Type: Expression profiling by high throughput sequencing.
Role of regorafenib in macrophage
GEO Series GSE148948. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Role of regorafenib in antitumor immunity in hepatocellular carcinoma
GEO Series GSE148947. Mus musculus. 32 samples. Type: Expression profiling by high throughput sequencing.
Analysis of differential gene expression in Regorafenib resistant human HCC cells either expressing or lacking Axl
GEO Series GSE234647. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
Spatial transcriptomics data of GAN-KP tumor treated with regorafenib
GEO Series GSE214363. Mus musculus. 2 samples. Type: Expression profiling by high throughput sequencing; Other.
Metastatic colorectal cancer patients treated with regorafenib before TAS-102 or viceversa: examples of radiologic restagings and survival follow-up.
<p>Metastatic colorectal cancer patients treated with regorafenib before TAS-102 or viceversa: examples of radiologic restagings and survival follow-up.</p>
Effect of Ketoconazole on Regorafenib (BAY73-4506) Pharmacokinetics
ClinicalTrials.gov study NCT01318265. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
ClinicalTrials.gov study NCT05113368. IPD Sharing: YES. Countries: 1. Publications: 0.
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
ClinicalTrials.gov study NCT06099821. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer
ClinicalTrials.gov study NCT06006923. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC
ClinicalTrials.gov study NCT05773105. IPD Sharing: NO. Countries: 1. Publications: 0.
REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
ClinicalTrials.gov study NCT02584465. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment
ClinicalTrials.gov study NCT03644511. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.
ClinicalTrials.gov study NCT06558773. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.